Clinical Study of Envafolimab Combined With Fruquintinib and Chemotherapy for Neoadjuvant Treatment of Gastric Cancer

PHASE2RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 20, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

May 31, 2027

Conditions

Gastric Cancer

Interventions

DRUG

Envafolimab

150mg/m2 , IH， d1；Q3W

DRUG

Fruquintinib

5 mg ，po，QD，d1-d14；Q3W

Trial Locations (1)

RECRUITING

The First Affiliated Hospital of Fujian Medical University, Fuzhou

All Listed Sponsors

lead

First Affiliated Hospital of Fujian Medical University

OTHER